Keith Brown explains how CRISPRclean improves transcriptional profiling and increases read coverage of 1000s of transcripts by removing the uninformative targets from single cell libraries while preserving cell type identification.
Investors include Baird Capital, Arboretum Ventures and LYZZ Capital; funding will accelerate commercialization of CRISPRclean™ next-generation sequencing technology Life sciences industry veteran Frank Witney joins […]
Kelsey Kaustinen details how Jumpcode’s CRISPRclean technology unites NGS and CRISPR/Cas editing in a Q&A with our Chief Scientist in the current issue of Drug […]
Patented CRISPRclean™ Technology is a Foundational Tool that Improves the Performance of Next-Generation Sequencing and Other Molecular Workflows by Increasing Sensitivity, Reducing Costs and Enabling Novel […]
Testimonials
Using JUMPCODE’s accurate, efficient depletion techniques together with high-throughput sequencing has been a real turning point for my research. We can now generate data from enough low amount of samples to have real statistical significance.
Laurey Steinke, PhD
Associate Professor, Nebraska Medical Center
CRISPRclean Technology
CRISPRclean is a proprietary technology that utilizes the CRISPR/CAS system to cut through the noise by removing unwanted nucleic acid molecules from sequencing libraries while preserving the representational integrity of the non-targeted sequences.
Researchers can benefit from an increased sensitivity and specificity in their areas of interest, use scarce and precious samples, and focus their sequencing cost on regions they care about without the worry of bias.
Get to know us
JOIN OUR TEAM
We're hiring multiple positions in San Diego, CA. See open positions
PRODUCTS
Researchers are using CRISPRclean kits in their RNA sequencing workflows to gain deeper insights in gene expression and transcriptome profiling studies. Learn more about CRISPRclean ribosomal RNA depletion products
COLLABORATE
We're looking for researchers, core directors, industry partners, and distributors. Fill out the contact form below to start the process.
About us
Founded in 2016, Jumpcode Genomics aims to improve the understanding of human biology and the contribution to disease. The company's proprietary CRISPRclean technology utilizes the CRISPR/Cas system to deplete unwanted nuclei acid molecules from sequencing libraries.
Thanks for your interest in Jumpcode Genomics
Get in touch with us for any questions or comments. We'd love to hear from you.